SecBot SecBot
DEFA14A ·Filed Jun 25, 2026

TECH

BIO-TECHNE Corp
BULLISH
Impact 8/10
Horizonmonths Processed4mo ago SEC0001999371-26-013514
Proxy solicitation materials
Actionable Insight ▲ Bullish

The $73.00 per share cash offer provides a clear floor for TECH stock, which should trade near that level minus deal risk and time value. Monitor regulatory and shareholder approval processes; any delays or competing bids could create volatility. Traders should consider the deal premium relative to pre-announcement price and the probability of closing.

DirectionBullish
Confidencehigh
Horizonmonths

How the stock moved after the report

BULLISH VIEWSTOCK ABOVE ENTRY AT T+60
Entry
$71.00
T+0 close · Jun 25, 2026 · via day close
Latest settled
+2.07%
T+60 · $72.47
Vs SPY
−4.04%
α at T+60
Horizons
All settled
through T+60
  1. T+0 · Jun 26 $71.00entry
  2. T+1 · 5mo ago −0.14%α −1.79% · $70.90
  3. T+5 · 4mo ago −0.24%α −2.41% · $70.83
  4. T+20 · 4mo ago +1.08%α −0.18% · $71.77
  5. T+60 · 8w ago +2.07%α −4.04% · $72.47
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

Bio-Techne has entered into a definitive agreement to be acquired by Merck KGaA for $73.00 per share in cash. The deal is expected to close by late 2026 or early 2027, subject to shareholder and regulatory approvals. This definitive additional proxy soliciting material communicates the terms and seeks support for the merger.

Key Financial Metrics

Vote
merger approval

Key Facts

  • Acquisition price: $73.00 per share in cash
  • Expected close: late 2026 or early 2027
  • Subject to shareholder approval and regulatory approvals
  • Employee stock options and RSUs will be cashed out at $73.00 per share

Financial Impact

$73.00 per share cash consideration for all outstanding shares of Bio-Techne

acquisition premiumcash consideration

Risk Factors

  • Regulatory approvals may not be obtained or could be delayed
  • Shareholders may reject the deal
  • A competing offer could emerge or the deal could be renegotiated

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
73% bullish (22 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001999371-26-013514
Document: 0001999371-26-013514-index-headers.html0001999371-26-013514
Document: 0001999371-26-013514-index.html0001999371-26-013514
Document: 0001999371-26-013514.txt0001999371-26-013514

Track record

12 reports on TECH

Performance horizon

3 of 3 bullish or bearish reports moved the stock their way by T+20. Best: +0.80% at T+60 after the Aug 10, 2026 report. 4 of 4 went positive at some point.

Filters
  1. Nov 12, 20264d ago 10-Q/A Neutral 1/10 Entry $72.80 Now $72.79 −0.01% settles Dec 14
  2. Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $72.66 Now $72.79 +0.18% settles Dec 4
  3. Nov 3, 202612d ago 8-K Neutral 2/10 Entry $72.73 Now $72.79 +0.08% settles Dec 3
  4. Nov 3, 202612d ago Press Release Neutral 2/10 Entry $72.73 Now $72.79 +0.08% settles Dec 3
  5. Oct 29, 202618d ago Institutional Cluster Bearish 4/10 Entry $72.71 Now $72.79 −0.11% settles Nov 27
  6. Oct 28, 202619d ago 10-K/A Neutral 3/10 Entry $72.71 Now $72.79 +0.11% settles Nov 27
  7. Sep 23, 20267w ago 8-K Bullish 6/10 Entry $72.57 to $72.62 Now $72.79 +0.30% ▲ +0.07% +0.49% vs SPY
  8. Sep 23, 20267w ago Press Release Bullish 6/10 Entry $72.52 to $72.64 Now $72.79 +0.37% ▲ +0.17% −0.52% vs SPY
  9. Aug 12, 202613w ago 8-K Bullish 7/10 No price data
  10. Aug 12, 202613w ago Press Release Neutral 4/10 Entry $72.23 to $72.08 Now $72.79 +0.78% ▼ −0.21% +1.69% vs SPY
Showing 10 of 12

US Market Status

Market Closed · Opens Wed (13h 37m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 25, 2026